Delivery Order SPE2DB24D2018-SPE2DB25FWSY4
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,199.02, is a Firm Fixed Price Delivery Order for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $48,034.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Dupixent 300 mg/2 ml pens, with a completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,932.05, is a delivery order for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,176.58, is for the delivery of Dupixent 300 mg/2 ml pens. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $4,862.96 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the specialty medication Dupixent 300 mg/2 ml pen with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,609.40 and is a delivery order with a firm fixed price. The contract covers the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a period of performance through November 15, 2023. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,819.41 Firm Fixed Price delivery order is for the supply of Dupixent 300 mg/2 ml pens to support federal healthcare programs. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order valued at $53,564.23 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The award, issued by the Defense Logistics Agency (DLA), is for the supply of the prescription medication Dupixent 300 mg/2 ml pen. The contract has a period of performance ending on September 25, 2024 and uses a firm fixed price pricing structure. Amerisourcebergen holds a broader indefinite delivery contract with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,305.79 delivery order contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication used for the treatment of various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $13,532.55, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of May 21, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...